Tweaking nerve‑cell protein partners to repair mood and motivation circuits
Probing brain circuit and behavior with protein:protein interaction modulators
Testing a new brain‑penetrating molecule that changes how two nerve‑cell proteins interact to try to restore circuits involved in mood, motivation, and reward.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-11284046 on NIH RePORTER |
What this research studies
From my perspective, researchers are creating small molecules that can enter the brain and alter the way two proteins on nerve cells work together, which may correct faulty signaling in brain areas that control mood and motivation. They used a light‑based screening method to search many compounds and optimized a lead molecule called 1028 that affects the interaction between the Nav1.6 ion channel and its regulator FGF14. The team will study how this probe changes nerve‑cell excitability in the nucleus accumbens and how that translates into behavior in lab models. The goal is to generate tools and data that could guide future therapies for psychiatric conditions linked to these circuits.
Who could benefit from this research
Good fit: People with mood and reward‑related conditions such as major depressive disorder with prominent anhedonia or substance use disorders would be the kinds of patients most likely to benefit from advances tied to this work.
Not a fit: Patients seeking immediate symptom relief, those with medical problems unrelated to brain reward/motivation circuits, or those needing established standard treatments would not expect direct benefit from this preclinical project.
Why it matters
Potential benefit: If successful, this work could open a new path toward precision drugs that restore circuit function for conditions like depression, anhedonia, or addiction.
How similar studies have performed: Modulating protein‑protein interactions is an emerging approach with encouraging preclinical results but limited proven clinical success so far.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Laezza, Fernanda — University of Texas Med Br Galveston
- Study coordinator: Laezza, Fernanda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.